Evidence map›Paper›PMID 37875931›Full record

ArticleBioPsychoSocial medicine2023

Psychological characteristics associated with the brain volume of patients with fibromyalgia.

Satoshi Izuno, Kazufumi Yoshihara, Masako Hosoi, Sanami Eto, Naoki Hirabayashi, Tae Todani, Motoharu Gondo, Chie Hayaki, Kozo Anno, Akio Hiwatashi and 1 more

Open access · goldAbstract read
In one paragraph

Article in BioPsychoSocial medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Satoshi IzunoDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Fukuoka, 812-8582, Japan.
Kazufumi YoshiharaDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Fukuoka, 812-8582, Japan. yoshihara.kazufumi.335@m.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0001-6499-3900
Masako HosoiDepartment of Psychosomatic Medicine, Kyushu University Hospital, Fukuoka, Japan.
Sanami EtoDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Fukuoka, 812-8582, Japan.
Naoki HirabayashiKyushu University Ito Clinic, Fukuoka, Japan.
Tae TodaniDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Fukuoka, 812-8582, Japan.
Motoharu GondoDepartment of Psychosomatic Medicine, Kyushu University Hospital, Fukuoka, Japan.
Chie HayakiDepartment of Psychosomatic Medicine, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
Kozo AnnoDepartment of Psychosomatic Medicine, Kyushu University Hospital, Fukuoka, Japan.
Akio HiwatashiDepartment of Radiology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Nobuyuki SudoDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Fukuoka, 812-8582, Japan.
Kyushu University · JPKyushu University Hospital · JPKyushu Central Hospital of the Mutual Aid Association of Public School Teachers · JPNagoya City University · JP

Funding

Japan Agency for Medical Research and Development JP19dm0307104Japan Agency for Medical Research and Development JP19ek0610015h0003Ministry of Education, Culture, Sports, Science and Technology JP16K15414Ministry of Education, Culture, Sports, Science and Technology JP19H03752Ministry of Education, Culture, Sports, Science and Technology JP20K03417Ministry of Health, Labour and Welfare JP19FG2001Ministry of Health, Labour and Welfare JP20FC1056
6 · The paper itself

Abstract

Fibromyalgia (FM) is a disease characterized by chronic widespread pain concomitant with psychiatric symptoms such as anxiety and depression. It has been reported that FM patients engage in pain catastrophizing. In this study, we investigated characteristics of the brain volume of female FM patients and the association between psychological indices and brain volume. Thirty-nine female FM patients and 25 female healthy controls (HCs) were recruited for the study, and five FM patients were excluded due to white matter lesions. The following analyses were performed: (1) T1-weighted MRI were acquired for 34 FM patients (age 41.6 ± 7.4) and 25 HCs (age 39.5 ± 7.4). SPM12 was used to compare their gray and white matter volumes. (2) Data from anxiety and depression questionnaires (State-Trait Anxiety Inventory and Hospital Anxiety and Depression Scale), the Pain Catastrophizing Scale (subscales rumination, helplessness, magnification), and MRI were acquired for 34 FM patients (age 41.6 ± 7.4). Correlation analysis was done of the psychological indices and brain volume. We found that (1) The white matter volume of the temporal pole was larger in the FM patient group than in the HC group. (2) Correlation analysis of the psychological indices and gray matter volume showed a negative correlation between trait anxiety and the amygdala. For the white matter volume, positive correlations were found between depression and the brainstem and between magnification and the postcentral gyrus. Changes in the brain volume of female FM patients may be related to anxiety, depression, and pain catastrophizing.

Indexed as

FibromyalgiaGray matterPain catastrophizingVoxel-based morphometryWhite matter

Identifiers

PMID37875931
PMCPMC10594713
OpenAlexW4387888487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.